← Eichor
Study identifier: NCT06266312 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer

Condition: Breast Cancer · Breast Neoplasms  ·  Sponsor: Maastricht University Medical Center

PhaseNA
Planned participants11
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this study is to investigate the feasibility of a multimodal prehabilitation programme consisting of MIET during neoadjuvant intravenous chemotherapy infusion, HITT and strength training during the last six weeks prior to surgery, and optimising nutritional intake throughout the total preoperative period in patients with breast cancer with respect to recruitment, adherence, dropout, safety and acceptance. The secondary objective is to provide a preliminary evaluation of participant responses to a preoperative multimodal lifestyle intervention, on cardiorespiratory fitness, muscle strength, nutritional status, and fatigue in patients with breast cancer receiving neoadjuvant chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Hanneke van Dijk - Huisman, PhD  ·  +31 43 3877146  ·  hanneke.huisman@mumc.nl

Anouk Weemaes, MSc  ·  +31 43 3877146  ·  anouk.weemaes@mumc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Maastricht University Medical CenterMaastricht, Limburg, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06266312